肠道菌群
肥胖
肥胖管理
医学
微生物群
生物信息学
生物
内科学
肠道微生物群
免疫学
减肥
作者
Jiafeng Geng,Qingqiang Ni,Wei Sun,Liangge Li,Xiujing Feng
标识
DOI:10.1016/j.biopha.2022.112678
摘要
The obesity epidemic has become a global public health crisis in recent years and is continuing to worsen at an alarming rate. However, the pathophysiological mechanisms involved in the development of obesity and obesity-related diseases are still being unraveled. In the past ten years, the gut microbiota has been identified as a crucial player affecting the onset and progression of obesity and obesity-related diseases, especially with respect to changes in its composition and metabolites during obesity progression. Herein, we summarize the roles and mechanisms of gut microbiota’s composition and metabolite changes in the gut play in obesity and obesity related diseases. Furthermore, we discuss potential therapeutic treatments that can be used to modulate the gut microbiome composition and target the relevant metabolic pathways of obesity and obesity-related metabolic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI